Investors

Azcuris — where an optimal research environment for pioneering immune disease therapeutics drives both individual growth and company-wide progress.

Azcuris Signs MOU with POSTECH Cell Membrane Protein Research Institut…

페이지 정보

Author admin
Views 60

Content

Azcuris Signs MOU with POSTECH Institute of Membrane Proteins for Next-Generation Drug Discovery

Azcuris Co., Ltd. and the Institute of Membrane Proteins (IMP) at Pohang University of Science and Technology (POSTECH) signed a memorandum of understanding on June 12, 2026, to jointly pursue structure-based drug discovery research.

The collaboration will leverage advanced infrastructure, including cryo-electron microscopy (Cryo-EM), to identify novel drug candidates and strengthen structural analysis capabilities.

Azcuris Co., Ltd.
CEO: Young-ho Jeon Business Registration No: 810-81-01249
Headquarters & R&D Center: 2511, Sejong-ro, Jochiwon-eup, Sejong-si, Republic of Korea
Additional Sites: Gyeongbuk R&D Center, Jeonbuk R&D Center, Seoul Business Center
Tel: 044-417-1543 Email: admin@azcuris.com
Copyright © 2021 Azcuris Co., Ltd.. Designed By ADS&SOFT | All rights reserved.